Unraveling Cancer Pain Dynamics (UColorado)
The goal of this initiative is to provide education to clinicians, involved in the assessment and management of cancer pain in adult patients, on the appropriate and safe use of opioid analgesics, optimizing non-opioid analgesics and adjuvant medications, and integrating non-pharmacological appro
Category
  • Pain
  • Palliative Care
  • Supportive Care Topics
Format
  • Live Webinar
Credits
  • 4.00 AAPA Category 1 CME credit
  • 4.00 ACPE contact hours
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 ANCC contact hours
  • 4.00 ASWB continuing education credit
  • 4.00 Participation
Cost $0.00
Unraveling Cancer Pain Dynamics (Yale)
The goal of this initiative is to provide education to clinicians, involved in the assessment and management of cancer pain in adult patients, on the appropriate and safe use of opioid analgesics, optimizing non-opioid analgesics and adjuvant medications, and integrating non-pharmacological appro
Category
  • Pain
  • Palliative Care
  • Supportive Care Topics
Format
  • Live Webinar
Credits
  • 4.00 AAPA Category 1 CME credit
  • 4.00 ACPE contact hours
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 ANCC contact hours
  • 4.00 ASWB continuing education credit
  • 4.00 Participation
Cost $0.00
NCCN 2024 Pharmacy Updates: A Webinar Series
This program will provide up-to-date knowledge and skills related to the management of cancer and highlight the importance of interprofessional care and collaboration to ensure the best possible outcomes for patients with cancer.
Category
Format
Credits
Cost $0.00
Recorded Presentation from the NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with Deficient Mismatch Repair
Treatment options for locally advanced or metastatic rectal cancer are evolving constantly. It is important for care teams to have an understanding of the current treatment approaches, toxicity management, and appropriate supportive care recommendations throughout a patient’s treatment course.
Category
  • Rectal Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities
By working through a series of realistic case scenarios, you will experience how to manage a variety of kidney cancer presentations over time. As you make decisions, you will receive expert corrective mentoring from virtual colleagues to help you recognize optimal decision-making patterns.
Category
  • Kidney Cancer
Format
  • Enduring Activity
Credits
Cost $0.00
NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer
Clinicians need to understand the diverse and evolving SDOH landscape, especially as it relates to clinical trial access for individuals with metastatic breast cancer (mBC), and they need to consider potential strategies to address SDOH to ensure equitable care and improve overall outcomes for patients with mBC.
Category
  • Breast Cancer
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Event date January 13, 2025
Cost $0.00
Unraveling Cancer Pain Dynamics (City of Hope)
The goal of this initiative is to provide education to clinicians, involved in the assessment and management of cancer pain in adult patients, on the appropriate and safe use of opioid analgesics, optimizing non-opioid analgesics and adjuvant medications, and integrating non-pharmacological appro
Category
  • Pain
  • Palliative Care
  • Supportive Care Topics
Format
  • Live Webinar
Credits
  • 4.00 AAPA Category 1 CME credit
  • 4.00 ACPE contact hours
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 ANCC contact hours
  • 4.00 ASWB continuing education credit
  • 4.00 Participation
Event date January 13, 2025
Cost $0.00
NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease
T-cell engager therapy with bispecific antibodies is emerging as a promising treatment option for patients with heavily pretreated DLBCL. Careful monitoring of adverse events and implementing appropriate supportive care strategies is important to maximize the clinical benefit.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Live Webinar
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Event date January 22, 2025
Cost $0.00

Pages